The intervention of valproic acid on the tumorigenesis induced by an environmental carcinogen of PAHs.
- Publisher:
- OXFORD UNIV PRESS
- Publication Type:
- Journal Article
- Citation:
- Toxicol Res (Camb), 2020, 9, (5), pp. 609-621
- Issue Date:
- 2020-09
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
The intervention of valproic acid on the tumorigenesis induced by an environmental carcinogen of PAHs.pdf | Published version | 3.4 MB |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
This study investigated whether valproic acid (VPA, a histone deacetylase inhibitor) can interfere with the carcinogenicity of polycyclic aromatic hydrocarbons (PAHs). A typical representative compound of PAHs, 7,12-Dimethylbenz[a]anthracene (DMBA), was used to induce rat breast cancer. The results showed that therapeutic concentration of VPA (50 and 100 mg/kg) delayed the occurrence of tumors, reduced tumor formation rate and attenuated tumors growth, and have a protective effect on normal tissues. The macrophage-mediated inflammatory response was found to be associated with the observed effect of VPA. In addition, we screened and validated a possible gene, Sema3c, which was involved in DMBA-induced breast cancer development and can be inhibited by VPA.
Please use this identifier to cite or link to this item: